Further Topics
![HF_infographic_card](/sites/default/files/at/en/2022-09/HF_infographic_card.jpeg)
Heart Diseases
Cardiovascular disease, including heart disease and stroke, is a major global health concern and the leading cause of death and disability worldwide.
![pexels-photo-6942000](/sites/default/files/at/en/2022-09/pexels-photo-6942000_1.jpeg)
Metabolic Diseases
About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 – 95 percent of all cases. This number is projected to increase to 629 million people by 2045.
![lib_org_D3pZd677](/sites/default/files/at/en/2022-09/lib_org_D3pZd677.jpg_1.jpg)
Cancer
Cancer takes. Takes away time. Takes away loved ones. At Boehringer Ingelheim we are providing new hope for patients by taking cancer on.
![Image 8 (1)](/sites/default/files/at/en/2022-11/Image%208%20%281%29.jpg)
Lung Diseases
Boehringer Ingelheim has 100 years of heritage in respiratory disease. Since 1921 we have emerged as a leader in this disease area.
![Our_responsibility](/sites/default/files/at/en/2022-09/Our_responsibility_0.jpg)
Skin Diseases
Living with inflammatory and fibrotic diseases greatly impacts patients’ lives, both physically and emotionally. These patients guide and inspire us to turn innovative science into life-changing medical breakthroughs.
![young-man-schizo](/sites/default/files/at/en/2022-09/young-man-schizo_0.jpg)
Mental Disorders
Central nervous system (CNS) diseases, including schizophrenia or Alzheimer’s disease, are a focus of Boehringer Ingelheim discovery research and development.
![Retinal Health Landing Page](/sites/default/files/at/en/2022-09/Retinal%20Health%20Landing%20Page.jpg)
Retinal Diseases
At Boehringer Ingelheim, we have expanded our global research and development activities to tackle eye diseases. Visual impairment and blindness have a profound and devastating impact on the lives of the affected person.